Long-lasting geroprotection from brief rapamycin treatment in early adulthood by persistently increased intestinal autophagy.

Paula Juricic, Yu-Xuan Lu, Thomas Leech, Lisa F Drews, Jonathan Paulitz, Jiongming Lu, Tobias Nespital, Sina Azami, Jennifer C Regan, Emilie Funk, Jenny Fröhlich, Sebastian Grönke, Linda Partridge
Author Information
  1. Paula Juricic: Max Planck Institute for Biology of Ageing, Cologne, Germany.
  2. Yu-Xuan Lu: Max Planck Institute for Biology of Ageing, Cologne, Germany. ORCID
  3. Thomas Leech: Max Planck Institute for Biology of Ageing, Cologne, Germany.
  4. Lisa F Drews: Max Planck Institute for Biology of Ageing, Cologne, Germany.
  5. Jonathan Paulitz: Max Planck Institute for Biology of Ageing, Cologne, Germany.
  6. Jiongming Lu: Max Planck Institute for Biology of Ageing, Cologne, Germany. ORCID
  7. Tobias Nespital: Max Planck Institute for Biology of Ageing, Cologne, Germany.
  8. Sina Azami: Max Planck Institute for Biology of Ageing, Cologne, Germany. ORCID
  9. Jennifer C Regan: Institute of Healthy Ageing, Department of Genetics, Evolution and Environment, University College London, London, UK. ORCID
  10. Emilie Funk: Max Planck Institute for Biology of Ageing, Cologne, Germany.
  11. Jenny Fröhlich: Max Planck Institute for Biology of Ageing, Cologne, Germany.
  12. Sebastian Grönke: Max Planck Institute for Biology of Ageing, Cologne, Germany. ORCID
  13. Linda Partridge: Max Planck Institute for Biology of Ageing, Cologne, Germany. linda.partridge@age.mpg.de. ORCID

Abstract

The licensed drug rapamycin has potential to be repurposed for geroprotection. A key challenge is to avoid adverse side effects from continuous dosing. Here we show that geroprotective effects of chronic rapamycin treatment can be obtained with a brief pulse of the drug in early adulthood in female Drosophila and mice. In Drosophila, a brief, early rapamycin treatment of adults extended lifespan and attenuated age-related decline in the intestine to the same degree as lifelong dosing. Lasting memory of earlier treatment was mediated by elevated autophagy in intestinal enterocytes, accompanied by increased levels of intestinal LManV and lysozyme. Brief elevation of autophagy in early adulthood itself induced a long-term increase in autophagy. In mice, a 3-month, early treatment also induced a memory effect, with maintenance similar to chronic treatment, of lysozyme distribution, Man2B1 level in intestinal crypts, Paneth cell architecture and gut barrier function, even 6 months after rapamycin was withdrawn.

References

  1. Sci Signal. 2009 Nov 24;2(98):ra75 [PMID: 19934433]
  2. J Gerontol A Biol Sci Med Sci. 2016 Jul;71(7):876-81 [PMID: 27091134]
  3. Science. 2010 Jan 8;327(5962):210-3 [PMID: 20056890]
  4. Nature. 2012 Jun 28;486(7404):490-5 [PMID: 22722868]
  5. Elife. 2021 May 14;10: [PMID: 33988501]
  6. Elife. 2021 Apr 21;10: [PMID: 33879316]
  7. Cell Metab. 2010 Jan;11(1):35-46 [PMID: 20074526]
  8. Science. 2017 Sep 8;357(6355):1047-1052 [PMID: 28751470]
  9. Sci Rep. 2017 Sep 20;7(1):11955 [PMID: 28931850]
  10. Cell Metab. 2012 May 2;15(5):713-24 [PMID: 22560223]
  11. iScience. 2018 Nov 30;9:229-243 [PMID: 30419503]
  12. Annu Rev Physiol. 2013;75:289-311 [PMID: 23398152]
  13. Nature. 2008 Nov 13;456(7219):259-63 [PMID: 18849966]
  14. Elife. 2016 Feb 16;5:e10956 [PMID: 26878754]
  15. Diabetes. 2008 Jun;57(6):1470-81 [PMID: 18305141]
  16. Exp Gerontol. 2009 Mar;44(3):228-35 [PMID: 18955126]
  17. Nature. 2009 Jul 16;460(7253):392-5 [PMID: 19587680]
  18. Aging Cell. 2014 Jun;13(3):529-39 [PMID: 24612461]
  19. Bioinformatics. 2006 Jul 1;22(13):1600-7 [PMID: 16606683]
  20. Aging Cell. 2014 Jun;13(3):468-77 [PMID: 24341993]
  21. Nature. 2017 Aug 31;548(7669):588-591 [PMID: 28847000]
  22. Gut. 2002 Mar;50(3):307-13 [PMID: 11839706]
  23. Oncogene. 2001 May 28;20(24):3021-7 [PMID: 11420717]
  24. Nat Biotechnol. 2008 Dec;26(12):1367-72 [PMID: 19029910]
  25. Methods. 2015 Mar;75:151-61 [PMID: 25481477]
  26. Aging Cell. 2013 Oct;12(5):851-62 [PMID: 23734717]
  27. Ann Appl Stat. 2016 Jun;10(2):946-963 [PMID: 28367255]
  28. J Proteome Res. 2011 Apr 1;10(4):1794-805 [PMID: 21254760]
  29. Nature. 2006 Jun 15;441(7095):885-9 [PMID: 16625204]
  30. Nature. 2019 Mar;567(7746):49-55 [PMID: 30814735]
  31. Cell Stem Cell. 2011 Jan 7;8(1):84-95 [PMID: 21167805]
  32. Exp Gerontol. 1992;27(3):321-33 [PMID: 1639152]
  33. Oncotarget. 2015 Nov 3;6(34):35274-83 [PMID: 26431326]
  34. Neuroscience. 2012 Oct 25;223:102-13 [PMID: 22750207]
  35. Aging Cell. 2012 Aug;11(4):675-82 [PMID: 22587563]
  36. Cell. 2015 Jul 2;162(1):72-83 [PMID: 26119340]
  37. Mol Brain. 2016 Jan 28;9:11 [PMID: 26822304]
  38. Elife. 2016 Aug 23;5: [PMID: 27549339]
  39. Cell Cycle. 2011 Dec 15;10(24):4230-6 [PMID: 22107964]
  40. PLoS Genet. 2010 Oct 14;6(10):e1001159 [PMID: 20976250]
  41. Nature. 2011 Jan 20;469(7330):415-8 [PMID: 21113151]
  42. Cell. 2014 Jan 16;156(1-2):109-22 [PMID: 24439372]
  43. Nature. 2013 Nov 14;503(7475):272-6 [PMID: 24089213]
  44. Sci Transl Med. 2018 Jul 11;10(449): [PMID: 29997249]
  45. EMBO Mol Med. 2018 Aug;10(8): [PMID: 29941542]
  46. Dev Cell. 2004 Aug;7(2):167-78 [PMID: 15296714]
  47. Front Aging Neurosci. 2021 Aug 02;13:697621 [PMID: 34408644]
  48. Front Immunol. 2020 Apr 03;11:587 [PMID: 32308658]
  49. Cell Cycle. 2007 Aug 1;6(15):1837-49 [PMID: 17671424]
  50. J Gerontol A Biol Sci Med Sci. 2007 Oct;62(10):1071-81 [PMID: 17921418]
  51. Science. 2012 Mar 30;335(6076):1638-43 [PMID: 22461615]
  52. Sci Transl Med. 2014 Dec 24;6(268):268ra179 [PMID: 25540326]
  53. Cell Rep. 2014 Sep 25;8(6):1767-1780 [PMID: 25199830]

MeSH Term

Animals
Female
Mice
Sirolimus
Muramidase
Paneth Cells
Drosophila
Autophagy

Chemicals

Sirolimus
Muramidase

Word Cloud

Created with Highcharts 10.0.0treatmentrapamycinearlyautophagyintestinalbriefadulthooddruggeroprotectioneffectsdosingchronicDrosophilamicememoryincreasedlysozymeinducedlicensedpotentialrepurposedkeychallengeavoidadversesidecontinuousshowgeroprotectivecanobtainedpulsefemaleadultsextendedlifespanattenuatedage-relateddeclineintestinedegreelifelongLastingearliermediatedelevatedenterocytesaccompaniedlevelsLManVBriefelevationlong-termincrease3-monthalsoeffectmaintenancesimilardistributionMan2B1levelcryptsPanethcellarchitecturegutbarrierfunctioneven6monthswithdrawnLong-lastingpersistently

Similar Articles

Cited By (52)